Gitte Dam

2.0k total citations
49 papers, 1.3k citations indexed

About

Gitte Dam is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Gitte Dam has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 28 papers in Hepatology and 15 papers in Surgery. Recurrent topics in Gitte Dam's work include Liver Disease and Transplantation (28 papers), Liver Disease Diagnosis and Treatment (24 papers) and Neuroendocrine Tumor Research Advances (15 papers). Gitte Dam is often cited by papers focused on Liver Disease and Transplantation (28 papers), Liver Disease Diagnosis and Treatment (24 papers) and Neuroendocrine Tumor Research Advances (15 papers). Gitte Dam collaborates with scholars based in Denmark, Spain and Italy. Gitte Dam's co-authors include Niels Kristian Aagaard, Hendrik Vilstrup, Hendrik Vilstrup, Lise Lotte Gluud, Mette Borre, Íñigo Les, Giulio Marchesini, Peter Jepsen, Hugh Watson and Peter Ott and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Analytical Biochemistry.

In The Last Decade

Gitte Dam

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gitte Dam Denmark 19 829 734 347 339 134 49 1.3k
Mette Borre Denmark 14 421 0.5× 414 0.6× 244 0.7× 303 0.9× 83 0.6× 25 819
W. Nolte Germany 14 564 0.7× 582 0.8× 332 1.0× 301 0.9× 28 0.2× 48 1.1k
Sun-Sang Wang Taiwan 19 689 0.8× 704 1.0× 463 1.3× 107 0.3× 144 1.1× 51 1.2k
Sherry Boyett United States 12 959 1.2× 512 0.7× 311 0.9× 164 0.5× 164 1.2× 19 1.2k
Marko Duvnjak Croatia 13 434 0.5× 171 0.2× 188 0.5× 119 0.4× 53 0.4× 56 825
R. J. Groszmann United States 21 1.3k 1.6× 1.8k 2.5× 941 2.7× 399 1.2× 50 0.4× 40 2.2k
Heather Hofflich United States 11 592 0.7× 223 0.3× 141 0.4× 108 0.3× 78 0.6× 18 1.0k
C Pera Spain 17 281 0.3× 433 0.6× 638 1.8× 72 0.2× 87 0.6× 29 1.0k
G.R. Swart Netherlands 16 516 0.6× 404 0.6× 114 0.3× 526 1.6× 13 0.1× 31 1.1k
John Colman Australia 13 409 0.5× 436 0.6× 194 0.6× 117 0.3× 31 0.2× 20 714

Countries citing papers authored by Gitte Dam

Since Specialization
Citations

This map shows the geographic impact of Gitte Dam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gitte Dam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gitte Dam more than expected).

Fields of papers citing papers by Gitte Dam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gitte Dam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gitte Dam. The network helps show where Gitte Dam may publish in the future.

Co-authorship network of co-authors of Gitte Dam

This figure shows the co-authorship network connecting the top 25 collaborators of Gitte Dam. A scholar is included among the top collaborators of Gitte Dam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gitte Dam. Gitte Dam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baunwall, Simon Mark Dahl, et al.. (2023). The role of N‐terminal pro‐brain natriuretic peptide, chromogranin A, and 5‐hydroxyindoleacetic acid in screening for carcinoid heart disease. Journal of Neuroendocrinology. 35(10). e13327–e13327. 2 indexed citations
2.
Aamann, Luise, Gitte Dam, Peter Jepsen, et al.. (2023). Reduced 3‐year risk of hospital admission and mortality after 12‐week resistance training of cirrhosis patients: A follow‐up of a randomized clinical trial. Journal of Gastroenterology and Hepatology. 38(8). 1365–1371. 4 indexed citations
3.
Nielsen, Mette Bak, et al.. (2023). Case of primary low-grade neuroendocrine carcinoma of the skin. BMJ Case Reports. 16(12). e257569–e257569. 1 indexed citations
4.
Sørensen, Michael, Anne B. Walls, Gitte Dam, et al.. (2022). Low cerebral energy metabolism in hepatic encephalopathy reflects low neuronal energy demand. Role of ammonia-induced increased GABAergic tone. Analytical Biochemistry. 654. 114766–114766. 17 indexed citations
5.
Grønbæk, Henning, et al.. (2022). Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients. Frontiers in Endocrinology. 13. 925632–925632. 9 indexed citations
6.
Dam, Gitte, et al.. (2021). First-generation somatostatin ligand receptor treatment in a pregnant patient with a neuroendocrine tumor with liver metastases. Endocrinology Diabetes and Metabolism Case Reports. 2021. 4 indexed citations
7.
Aamann, Luise, Gitte Dam, Mette Borre, et al.. (2019). Resistance Training Increases Muscle Strength and Muscle Size in Patients With Liver Cirrhosis. Clinical Gastroenterology and Hepatology. 18(5). 1179–1187.e6. 75 indexed citations
8.
Dam, Gitte, Henning Grønbæk, Halfdan Sørbye, et al.. (2019). Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors. Neuroendocrinology. 110(3-4). 217–224. 31 indexed citations
9.
Aamann, Luise, Rafael Ochoa‐Sanchez, Mélanie Tremblay, et al.. (2018). Progressive resistance training prevents loss of muscle mass and strength in bile duct‐ligated rats. Liver International. 39(4). 676–683. 13 indexed citations
10.
Dam, Gitte, et al.. (2018). The role of Branched Chain Amino Acids in the treatment of hepatic Encephalopathy. Journal of Clinical and Experimental Hepatology. 8(4). 448–451. 24 indexed citations
11.
12.
Campollo, Octavio, D. Sprengers, Gitte Dam, Hendrik Vilstrup, & Neil McIntyre. (2017). Protein tolerance to standard and high protein meals in patients with liver cirrhosis. World Journal of Hepatology. 9(14). 667–667. 20 indexed citations
13.
Bémeur, Chantal, Cristina Cudalbu, Gitte Dam, et al.. (2016). Brain edema: a valid endpoint for measuring hepatic encephalopathy?. Metabolic Brain Disease. 31(6). 1249–1258. 24 indexed citations
14.
Gluud, Lise Lotte, Gitte Dam, Íñigo Les, et al.. (2015). Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database of Systematic Reviews. CD001939–CD001939. 54 indexed citations
15.
Dam, Gitte, et al.. (2015). P0113 : Regional cerebral water content in hepatic encephalopathy measured by MRI. Journal of Hepatology. 62. S343–S343. 1 indexed citations
16.
Becker, Sören L., Gitte Dam, & Christian Lodberg Hvas. (2014). Refeeding encephalopathy in a patient with severe hypophosphataemia and hyperammonaemia. European Journal of Clinical Nutrition. 69(2). 279–281. 9 indexed citations
17.
Gluud, Lise Lotte, Gitte Dam, Mette Borre, et al.. (2013). Oral Branched-Chain Amino Acids Have a Beneficial Effect on Manifestations of Hepatic Encephalopathy in a Systematic Review with Meta-Analyses of Randomized Controlled Trials. Journal of Nutrition. 143(8). 1263–1268. 89 indexed citations
18.
Dam, Gitte, Peter Ott, Niels Kristian Aagaard, & Hendrik Vilstrup. (2013). Branched-chain amino acids and muscle ammonia detoxification in cirrhosis. Metabolic Brain Disease. 28(2). 217–220. 61 indexed citations
19.
Gluud, Lise Lotte, Gitte Dam, Mette Borre, et al.. (2012). Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?. Metabolic Brain Disease. 28(2). 221–225. 65 indexed citations
20.
Dam, Gitte, et al.. (2008). Intestinal obstruction and bacteremia – complications of capsule endoscopy. Endoscopy. 40(S 02). E155–E156. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mette Borre Breakdown of academic impact, for papers by W. Nolte Breakdown of academic impact, for papers by Sun-Sang Wang Breakdown of academic impact, for papers by Sherry Boyett Breakdown of academic impact, for papers by Marko Duvnjak Breakdown of academic impact, for papers by R. J. Groszmann Breakdown of academic impact, for papers by Heather Hofflich Breakdown of academic impact, for papers by C Pera Breakdown of academic impact, for papers by G.R. Swart Breakdown of academic impact, for papers by John Colman
Rankless by CCL
2026